3 hours Zimmer Biomet (NYSE:ZBH) Price Target Cut to $120.00 MarketBeat
Royal Bank of Canada decreased their target price on shares of Zimmer Biomet from $130.00 to $120.00 and set an “outperform” rating for the company in a research report on Tuesday.
Canada · NYSE · Royal Bank of Canada · Science · Zimmer Biomet (ZBH)